Relationship between umbilical cord essential fatty acid content and the quality of general movements of healthy term infants at 3 months

Pediatric Research

Volumn 59, Issue 5, 2006, Pages 717-722

  Bouwstra, Hylco ^a   Dijck Brouwer, Da Janneke ^a   Decsi, Tamás ^b   Boehm, Günther ^c   Boersma, E Rudy ^a   Muskiet, Frits A J ^a   Hadders Algra, Mijna ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Numico Research Germany   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ESSENTIAL FATTY ACID; MONOUNSATURATED FATTY ACID;

ARTICLE; BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; LIPID COMPOSITION; LOGISTIC REGRESSION ANALYSIS; MALE; MOVEMENT (PHYSIOLOGY); MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; UMBILICAL ARTERY; UMBILICAL CORD; UMBILICAL VEIN;

CENTRAL NERVOUS SYSTEM; CHILD DEVELOPMENT; DOUBLE-BLIND METHOD; FATTY ACIDS; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; MOTOR ACTIVITY; PREGNANCY; UMBILICAL ARTERIES;

EID: 33646676300     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000215013.19164.57     Document Type: Article

References (32)

1. Martínez M, Mougan I 1998 Fatty acid composition of human brain phospholipids during normal development. J Neurochem 71:2528-2533
2. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW 1980 Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4:121-9
3. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW 1992 Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 340:810-813
4. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJ, Logan RW, Cockburn F 1995 Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 72:198-203
5. Agostoni C, Trojan S, Bellu R, Riva E, Giovannini M 1995 Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res 38:262-266
6. Bouwstra H, Dijck-Brouwer DA, Wildeman JA, Tjoonk HM, van der Heide JC, Boersma ER, Muskiet FA, Hadders-Algra M 2003 Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am J Clin Nutr 78:313-318
7. Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E, Jamieson C, Cockbum F, Lucas A 2004 Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 144:471-479
8. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants bom at term. Cochrane Database of Systematic Reviews [database online] 2001, issue 4, article no. CD000376. DOI: 10.1002/14651858.CD000376.
9. Bouwstra H, Dijck-Brouwer DA, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M 2005 Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatr 94:26-32
10. Agostoni C, Trojan S, Bellu R, Riva E, Bruzzese MG, Giovannini M 1997 Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch Dis Child 76:421-424
11. Dijck-Brouwer DA, Hadders-Algra M, Bouwstra H, Decsi T, Boehm G, Martini IA, Boersma ER, Muskiet FA 2005 Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favorable neonatal neurological condition. Prostaglandins Leukot Essent Fatty Acids 72:21-28
12. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T, Drevon CA 2001 Similar effects on infants of ω3 and ω6 fatty acids supplementation to pregnant and lactating women. Pediatrics 8:E82
13. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA 2003 Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111:e39-e44
14. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT 2003 Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed 88:F383-F390
15. Ghys A, Bakker E, Homstra G, van den Hout M 2002 Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev 69:83-90
16. Bakker EC, Ghys AJ, Kester AD, Vles JS, Dubas JS, Blanco CE, Homstra G 2003 Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr 57:89-95
17. Bouwstra H, Boersma ER, Boehm G, Dijck-Brouwer DA, Muskiet FA, Hadders-Algra M 2003 Exclusive breastfeeding of healthy term infants for at least 6 weeks improves neurological condition. J Nutr 133:4243-4245
18. Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D 1997 An early marker for neurological deficits after perinatal brain lesions. Lancet 349:1361-1363
19. Hadders-Algra M, Groothuis AM 1999 Quality of general movements in infancy is related to neurological dysfunction, ADHD, and aggressive behaviour. Dev Med Child Neurol 41:381-391
20. Hadders-Algra M, Mavinkurve-Groothuis AM, Groen SE, Stremmelaar EF, Martijn A, Butcher PR 2004 Quality of general movements and the development of minor neurological dysfunction at toddler and school age. Clin Rehabil 18:287-299
21. Groen SE, de Blécourt AC, Postema K, Hadders-Algra M 2005 General movements in early infancy predict neuromotor development at 9-12 years of age. Dev Med Child Neurol 47:731-738
22. Muskiet FA, van Doormaal JJ, Martini JA, Wolthers BG, van der Slik W 1983 Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr 278:231-244
23. Decsi T, Boehm G, Tjoonk HM, Molnar S, Dijck-Brouwer DA, Hadders-Algra M, Martini IA, Muskiet FA, Boersma ER 2002 Trans isomeric octadecenoic acids are related inversely to arachidonic acid and DHA and positively related to mead acid in umbilical vessel wall lipids. Lipids 37:959-965
24. Hadders-Algra M 2004 General movements: a window for early identification of children at high risk for developmental disorders. J Pediatr 145:S12-S18
25. Touwen BC, Huisjes HJ, Jurgens-van der Zee AD, Bierman-van Eendenburg ME, Smrkovsky M, Olinga AA 1980 Obstetrical condition and neonatal neurological morbidity. An analysis with the help of the optimality concept. Early Hum Dev 4:207-208
26. Bradley RH, Caldwell BM, Brisby J, Magee M, Whiteside L, Rock SL 1992 The HOME inventory: a new scale for families of pre- and early adolescent children with disabilities. Res Dev Disabil 13:313-333
27. Mulder EJ, Morssink LP, van der Schee T, Visser GH 1998 Acute maternal alcohol consumption disrupts behavioral state organization in the near-term fetus. Pediatr Res 44:774-779
28. Widdowson EM 1968 Growth and composition of the fetus and newborn. In: Assali NS Biology of Gestation. Academic Press, New York, pp 1-49
29. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KE 2001 The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 40:1-94
30. Uauy R, Hoffman DR, Mena P, Llanos A, Birch EE 2003 Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 143:517-525
31. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW 1980 Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 4:131-138
32. Agostoni C, Verduci E, Massetto N, Radaelli G, Riva E, Giovannini M 2003 Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Dev Med Child Neurol 45:257-261